Dr. Sercan Karabulut is an accomplished psychiatrist and academic currently serving at the Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey. He earned his Doctor of Medicine (MD) and completed his Psychiatry Residency at the İstanbul Medicine Faculty, where his scientific interest in the neurobiological mechanisms underlying mental disorders was first cultivated. Over the past decade, he has developed an exceptional academic and clinical career across leading institutions, including Antalya Atatürk State Hospital and Van Bölge Research and Training Hospital, focusing on the diagnosis, treatment, and prevention of psychiatric and substance use disorders. His primary research interests encompass addiction psychiatry, psychotic and mood disorders, neuroinflammation, and methamphetamine-related psychopathology, with a special focus on cognitive impairment and gender-based differences in substance use. Dr. Sercan Karabulut has authored 18 scientific publications, accumulating 195 citations from 193 documents and maintaining an h-index of 5, as indexed in Scopus (ID: 56073897200). His works have appeared in prominent journals, including Acta Neuropsychiatrica, Turkish Journal of Psychiatry, Journal of Drug Issues, and Alpha Psychiatry. Notable studies such as Inflammation and Neurodegeneration in Bipolar Disorder (2019) and Frequency of Methamphetamine Use (2024) have been widely cited and advanced the understanding of neuropsychiatric pathophysiology.
Profile: Scopus | ORCID | ResearchGate
